ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.00%
US Dollar vs MXN
16.9639
0.12%
Brent Oil
84.32
0.93%
Bitcoin
58,588.14
0.60%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Acurx Pharmaceuticals Inc (ACXP)

  7. Acurx Pharmaceuticals Inc (ACXP) Noticias

ACXP Acurx Pharmaceuticals Inc

2.16
0.00 (0.00%)
Pre Mercado
Última actualización: 06:00:07
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Acurx Pharmaceuticals Inc ACXP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 2.16 06:00:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.16
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202406:00PRNUSAcurx Pharmaceuticals Announces Presentation of Ibezapolstat..
25/4/202409:12PRNUSAcurx Pharmaceuticals Announces Presentation of..
23/4/202409:57PRNUSAcurx Pharmaceuticals, Inc. to Discuss First Quarter 2024..
19/3/202406:33IHMARKETNEWSUnilever Initiates Ice Cream Division Spin-Off and Announces..
18/3/202406:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
18/3/202406:01PRNUSAcurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full..
04/3/202406:01PRNUSAcurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and..
27/2/202406:01PRNUSAcurx Announces FDA Has Granted an End of Phase 2 Meeting..
23/2/202408:30GLOBENew to The Street Announces Line-up of its Corporate..
16/2/202408:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
02/2/202408:30GLOBENew to The Street Announces its 553rd Episode TV Line Up,..
01/2/202408:33GLOBENew to The Street TV Announces Episode #552 with its Five..
29/1/202406:00PRNUSAcurx Announces Positive Extended Clinical Cure Data for..
26/1/202409:55GLOBENew to The Street Announces Episode 551, Five Corporate..
23/1/202406:01PRNUSAcurx Pharmaceuticals to Present at the Microcap Conference,..
22/1/202405:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202408:30GLOBENew to The Street Airs on the FOX Business Network, Episode..
17/1/202406:01PRNUSAcurx Announces Positive Comparative Microbiology and..
05/1/202408:30GLOBENew to The Street Announces its Four Corporate Interviews,..
03/1/202407:00PRNUSAcurx to present at the 42nd Annual J.P. Morgan Healthcare..
11/12/202306:01PRNUSAcurx Announces Positive Phase 2b Results Showing 100% of..
08/12/202308:46GLOBENew to The Street TV Features Five Corporate Guest..
07/12/202308:20GLOBENew to The Street TV Announces Its Episode 536 Lineup, Five..
01/12/202308:30GLOBENew to The Street Announces Five Corporate Interviews,..
24/11/202308:30GLOBENew to The Street Announces its Five Business Guest..
17/11/202308:30GLOBENew to The Street Announces Episode 530 with Six Corporate..
15/11/202316:02EDGAR2Form 8-K - Current report
15/11/202315:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/11/202306:01PRNUSAcurx Pharmaceuticals, Inc. Reports Third Quarter 2023..
02/11/202306:01PRNUSAcurx Announces Positive Top-Line Ibezapolstat Phase 2..
25/10/202306:01PRNUSAcurx Pharmaceuticals to Discuss Third Quarter 2023..
20/10/202309:43GLOBENew to The Street Announces Six Business Interviews on its..
19/10/202306:01PRNUSAcurx Announces Ibezapolstat Scientific Posters and..
02/10/202306:01PRNUSAcurx Pharmaceuticals Announces Successful Completion and..
12/9/202306:01PRNUSAcurx Announces Presentation and Update of Its pol IIIC R&D..
22/8/202306:01PRNUSAcurx Pharmaceuticals to Present at the H.C. Wainwright 25th..
14/8/202306:01PRNUSAcurx Pharmaceuticals, Inc. Reports Second Quarter 2023..
24/7/202306:01PRNUSAcurx Pharmaceuticals to Discuss Second Quarter 2023..
13/7/202315:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/7/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
07/7/202308:30GLOBENew to The Street Airs its Televised Corporate Interviews on..
30/6/202308:35GLOBENew to The Street TV / Newsmax TV Announces its Five..
20/6/202306:01PRNUSAcurx Pharmaceuticals to Present at the Emerging Growth..
15/6/202306:01PRNUSAcurx Pharmaceuticals to Participate in the Maxim Group LLC..
16/5/202307:45PRNUSAcurx Pharmaceuticals, Inc. Announces Pricing of $4.0..
12/5/202306:01PRNUSAcurx Pharmaceuticals, Inc. Reports First Quarter 2023..
05/5/202316:01PRNUSAcurx Pharmaceuticals to Discuss First Quarter 2023..

Su Consulta Reciente

NASDAQ
ACXP
Acurx Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados